Showing 1 - 10 of 228
Evaluation of projects that affect mortality risk usually assumes that risk changes are small and similar across individuals. In reality, risks differ among individuals and information about risk heterogeneity determines the extent to which affected lives are “statistical” or...
Persistent link: https://www.econbiz.de/10005678192
Persistent link: https://www.econbiz.de/10012627503
Persistent link: https://www.econbiz.de/10010926697
Persistent link: https://www.econbiz.de/10005306801
Persistent link: https://www.econbiz.de/10005270626
Persistent link: https://www.econbiz.de/10010694077
Persistent link: https://www.econbiz.de/10012543889
Persistent link: https://www.econbiz.de/10013483464
Valuing the health of children for cost-utility or cost-benefit analysis poses a number of additional challenges when compared with valuing adult health. Some of these challenges relate to the inability of young children to value changes in health directly and the potential biases associated...
Persistent link: https://www.econbiz.de/10010848926
The value of reducing health and mortality risks is often measured using value per statistical life (VSL) or one of several life-year measures (e.g., life years, quality-adjusted life years, disability-adjusted life years). I derive the utility function that is admissible when preferences for...
Persistent link: https://www.econbiz.de/10010863421